Doximity Approves $500 Million Stock Buyback

The medical networking platform plans to repurchase up to 8% of its outstanding shares.

Published on Feb. 5, 2026

Got story updates? Submit your updates here. ›

Doximity (NASDAQ:DOCS), a leading professional medical network for healthcare professionals in the United States, has announced that its board of directors has approved a $500 million stock buyback program. The company plans to repurchase up to 8% of its outstanding shares through open market purchases.

Why it matters

Stock buybacks are often seen as a sign that a company's leadership believes its shares are undervalued. This move by Doximity suggests the company has confidence in its long-term growth prospects and is willing to invest in itself by repurchasing its own stock.

The details

The $500 million stock buyback authorization allows Doximity to purchase up to 8% of its outstanding shares. The company will execute the buybacks through open market transactions. Doximity's decision to initiate this buyback program comes as the company's stock price has declined from its 52-week high of $85.21.

  • Doximity's board of directors approved the $500 million stock buyback program on Thursday, February 5, 2026.

The players

Doximity

A leading professional medical network for healthcare professionals in the United States, headquartered in San Francisco, California.

Got photos? Submit your photos here. ›

What’s next

Doximity will begin executing the stock buyback program in the coming weeks and months, with the goal of repurchasing up to 8% of its outstanding shares.

The takeaway

Doximity's $500 million stock buyback program signals the company's confidence in its long-term growth prospects and its belief that its shares are currently undervalued. This move could help support the stock price and demonstrate Doximity's commitment to creating shareholder value.